2023-09-29 04:30:00
Developed by the Sanofi group, Beyfortus has met with unexpected success. Authorized on the European market since 2022, this preventive treatment against respiratory tract infections in newborns and infants is so popular that doses are already starting to run out. At its launch, the State had ordered 200,000 doses, for 120,000 births over the year, counting on a smooth start to the first immunization campaign which began on September 15.
However, it turns out that young parents, far from being resistant to this preventive treatment against bronchiolitis, have…
1695963292
#Lorraine #Immunization #babies #bronchiolitis #victim #success
Related posts:
Manon's Battle Against Leukemia: A Story of Hope and Courage
Lionel Messi's Debut for Inter Miami Sparks Massive Ticket Sales: Get Your Seats Now!
BUAP Medicine student loses his life in a strong crash - El Sol de Puebla
Remco Evenepoel, winner for the sixth time this season: "I'm really happy"
Krasnodar vs Baltika: Match Review, Goals, Line-Up, and Highlights from Russian Premier League 21st ...
Xavi, Lewandowski and 10 other Barcelona players received one star from Marca for the match against ...
This drug combining ibuprofen and codeine can lead to death in the event of prolonged intake or over...
Rak Chumphon Pongchamp won the championship in Suek Jao Muay Thai